SYMFI (Page 16 of 16)
PRINCIPAL DISPLAY PANEL — 600 mg/300 mg/300 mg
NDC 49502-475-93 Rx only
SYMFI®
(efavirenz, lamivudine,
and tenofovir disoproxil
fumarate) tablets
600 mg/300 mg/300 mg*
Note to pharmacist: Do not cover
ALERT box with pharmacy label.
ALERT: Find out about
medicines that should NOT
be taken with SYMFI®.
30 tablets
*Each film-coated tablet contains:
Efavirenz, USP 600 mg
Lamivudine, USP 300 mg
Tenofovir Disoproxil Fumarate 300 mg
(equivalent to 245 mg of tenofovir
disoproxil)
Usual Dosage: See accompanying
prescribing information.
Keep this and all medication
out of the reach of children.
Store below 30°C (86°F).
Dispense only in original container.
Keep container tightly closed.
Manufactured for:
Mylan Specialty L.P.
Morgantown, WV 26505 U.S.A.
Made in India
Code No.: MP/DRUGS/25/1/2014
MS:MXI:47593:1C:R3
Mylan.com
SYMFI® is a registered
trademark of Mylan Pharmaceuticals Inc.
SYMFI efavirenz, lamivudine and tenofovir disoproxil fumarate tablet, film coated | ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
|
Labeler — Mylan Specialty L.P. (194775557) |
Revised: 10/2019 Mylan Specialty L.P.
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.